Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04486833
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2020-07-22
Brief Title:
Quaratusugene Ozeplasmid Reqorsa and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Sponsor:
Organization:
Genprex Inc